HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VPAC receptor mediated tumor cell targeting by protamine based nanoparticles.

Abstract
The receptors for vasoactive intestinal peptide (VIP), VPAC1-, VPAC2-, and PAC1-receptor are overexpressed by various tumor cells. VIP can target these receptors and transport conjugates into the cell. However, the use of VIP for tumor cell targeting is hampered by the peptides short half-lives due to enzymatic degradation. Because protamine-based nanoparticles (proticles) protect the peptide and serve as peptide depot, we explored the potential of proticles as carrier for VIP-conjugated molecules. The VIP-loaded proticles were stable as shown by Fluorescence Correlation Spectroscopy. With Confocal Laser Scanning Microscopy, we observed VIP-loaded proticles to specifically target the tumor cells. The cell binding triggered the substance release and conjugate internalization of VIP-Cy3 in vitro and ex vivo by human tumors. We observed VIP releasing proticle depots distributed in rat tissue and human tumors. Our findings warrant further studies to explore the proticles potential to enable peptide-mediated targeting for in vivo and clinical applications.
AuthorsAnna Ortner, Karin Wernig, Raphaela Kaisler, Michael Edetsberger, Franz Hajos, Gottfried Köhler, Wilhelm Mosgoeller, Andreas Zimmer
JournalJournal of drug targeting (J Drug Target) Vol. 18 Issue 6 Pg. 457-67 (Jul 2010) ISSN: 1029-2330 [Electronic] England
PMID20050817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protamines
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
  • Receptors, Vasoactive Intestinal Peptide, Type II
  • Receptors, Vasoactive Intestinal Polypeptide, Type I
  • Vasoactive Intestinal Peptide
Topics
  • Animals
  • Arteries (drug effects, metabolism)
  • Cell Line, Tumor
  • Drug Stability
  • Humans
  • Immunohistochemistry
  • In Vitro Techniques
  • Nanoparticles (chemistry)
  • Neoplasms (metabolism, pathology)
  • Particle Size
  • Protamines (chemistry)
  • Rats
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I (biosynthesis)
  • Receptors, Vasoactive Intestinal Peptide, Type II (biosynthesis)
  • Receptors, Vasoactive Intestinal Polypeptide, Type I (biosynthesis)
  • Spectrometry, Fluorescence
  • Vasoactive Intestinal Peptide (administration & dosage, pharmacokinetics, pharmacology)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: